CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Tumor-infiltrating CD8+ T cells are strongly associated with patient survival in a wide variety of human cancers. Less is known about tumor-infiltrating CD20+ B cells, which often colocalize with T cells, sometimes forming organized lymphoid structures. In autoimmunity and organ transplantation, T cells and B cells collaborate to generate potent, unrelenting immune responses that can result in extensive tissue damage and organ rejection. In these settings, B cells enhance T cell responses by producing Abs, stimulatory cytokines, and chemokines, serving as local APCs, and organizing the formation of tertiary lymphoid structures that sustain long-term immunity. Thus, B cells are an important component of immunological circuits associated with persistent, rampant tissue destruction. Engagement of tumor-reactive B cells may be an important condition for generating potent, long-term T cell responses against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
Sarwal, M., Chua, M.-S., Kambham, N., Hsieh, S.-C., Satterwhite, T., Masek, M., & Salvatierra, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035588 · Cited by 701
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Cytokine-producing B lymphocytes-key regulators of immunity
Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556
Cited by
Items 201–300 of 461
Taghavi, N., Mohsenifar, Z., Baghban, A. A., & Arjomandkhah, A. (2018) · Pathology Research International · doi:10.1155/2018/4810751 · Cited by 30
Millar, E. K. A., Browne, L. H., Šlapetová, I., Shang, F., Ren, Y., Bradshaw, R., Brauer, H. A., O’Toole, S. A., Beretov, J., Whan, R. M., et al. (2020) · Cancers · doi:10.3390/cancers12092365 · Cited by 30
Ho, K., Chang, C., Huang, T., Shih, C.-M., Liu, A.-J., Chen, P., Cheng, K., & Chen, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208459 · Cited by 29
Phanthunane, C., Wijers, R., de Herdt, M., Langeveld, T. P. M., Koljenović, S., Dasgupta, S., Sleijfer, S., de Jong, R. J. B., Hardillo, J. A., Balcioglu, H. E., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1882743 · Cited by 28
Jang, J., Thuy, P. X., Lee, J., & Moon, E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03615-w · Cited by 28
Aziz, H. M., Saida, L., de Koning, W., Stubbs, A., Li, Y., Sideras, K., Palacios, E., Feliú, J., Mendiola, M., van Eijck, C. H. J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.995715 · Cited by 28
Liu, J., Li, Y., Zhou, L., Gu, J., Liang, Y., Huang, E., Wang, Z., Zhang, H., Wang, L., Zhang, D., et al. (2018) · Immunology · doi:10.1111/imm.12998 · Cited by 28
Naciūtė, M., Niemi, V., Kemp, R. A., & Hook, S. M. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.04.020 · Cited by 27
Colorectal cancer vaccines in clinical trials
Speetjens, F. M., Zeestraten, E. C. M., Kuppen, P. J. K., Melief, C. J. M., & van der Burg, S. H. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.63 · Cited by 27
Panico, L., Tenneriello, V., Ronconi, F., Lepore, M., Cantore, N., Dell’Angelo, A. C., Ferbo, L., & Ferrara, F. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.951849 · Cited by 26
Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model
Yeung, H., Lo, P., Ng, D. K. P., & Fong, W. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.84 · Cited by 26
Gholiha, A. R., Hollander, P., Hedström, G., Sundström, C., Molin, D. L., Smedby, K. E. E., Hjalgrim, H., Glimelius, I. C., Amini, R., & Enblad, G. (2018) · British Journal of Haematology · doi:10.1111/bjh.15703 · Cited by 26
Brand, M., Laban, S. A., Theodoraki, M., Doescher, J., Hoffmann, T. K., Schuler, P. J., & Brunner, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010247 · Cited by 26
External cues to drive B cell function towards immunotherapy
Stoycheva, D., Şimşek, H., Weber, W., Hauser, A. E., & Klotzsch, E. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.026 · Cited by 26
Immune-Activated B Cells Are Dominant in Prostate Cancer
Saudi, A., Banday, V. S., Zirakzadeh, A. A., Selinger, M., Forsberg, J., Holmbom, M., Henriksson, J., Waldén, M., Alamdari, F. I., Aljabery, F. A.-S., et al. (2023) · Cancers · doi:10.3390/cancers15030920 · Cited by 25
Zou, Y., Hu, J., Jie, J., Lai, J., Li, M., Liu, Z., & Zou, X. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103616 · Cited by 25
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
Zha, H., Jiang, Y., Wang, X., Shang, J., Wang, N., Yu, L., Zhao, W., Li, Z., Zhang, X., Zhang, X., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001230 · Cited by 25
Role of B-cells in Mycosis Fungoides
Nielsen, P. R., Eriksen, J., Sørensen, M., Wehkamp, U., Lindahl, L. M., Bzorek, M., Iversen, L., Woetmann, A., Ødum, N., Litman, T., et al. (2021) · Acta Dermato Venereologica · doi:10.2340/00015555-3775 · Cited by 25
PLAN B for immunotherapy: Promoting and leveraging anti-tumor B cell immunity
Shi, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.028 · Cited by 25
Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
Ding, Y., Qiu, L., Xu, Q., Song, L., Yang, S., & Yang, T. (2014) · PubMed · Cited by 25
Zhang, C., Li, J., Wang, H., & Song, S. W. (2016) · Oncotarget · doi:10.18632/oncotarget.12605 · Cited by 25
PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors
Haro, M., Littrell, C. A., Yin, Z., Huang, X., & Haas, K. M. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0184 · Cited by 25
Tamma, R., Limongelli, L., Maiorano, E., Pastore, D., Cascardi, E., Tempesta, A., Carluccio, P., Mastropasqua, M. G., Capodiferro, S., Covelli, C., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3575-3 · Cited by 24
A Lower Proportion of Regulatory B Cells in Patients with Henoch–Schoenlein Purpura Nephritis
Hu, X., Tai, J., Qu, Z., Zhao, S., Zhang, L., Li, M., Sun, X., & Jiang, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152368 · Cited by 24
Sheppard, H., Vogel, P., Rogers, T. D., Akers, W. J., & Rehg, J. E. (2020) · Veterinary Pathology · doi:10.1177/0300985820913265 · Cited by 24
Jiang, M., Fiering, S., & Shao, Q. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1153066 · Cited by 23
Participation of B cell in immunotherapy of cancer
Chandnani, N., Gupta, I., Mandal, A., & Sarkar, K. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155169 · Cited by 23
Immune cell recruitment in teratomas is impaired by increased Wnt secretion
Augustin, I., Dewi, D. L., Hundshammer, J., Rempel, E., Brunk, F., & Boutros, M. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.10.010 · Cited by 23
Yang, J., Dang, G., Lü, S., Liu, H., Ma, X., Han, L., Deng, J., Miao, Y., Li, X., Shao, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900863r · Cited by 23
Zinovkin, D. A., Kose, S. Y., Nadyrov, E. A., Ачинович, С. Л., Los’, D. M., Gavrilenko, T. E., Гавриленко, Д. И., Yüzügülen, J., & Pranjol, M. Z. I. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120052 · Cited by 23
The Role of B Cells in Head and Neck Cancer
Gavrielatou, N., Vathiotis, I. A., Economopoulou, P., & Psyrri, A. K. (2021) · Cancers · doi:10.3390/cancers13215383 · Cited by 22
Priyamvada, P., & Ramaiah, S. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10544-0 · Cited by 22
Mehdipour, F., Razmkhah, M., Hosseini, A., Bagheri, M., Safaei, A., Talei, A., & Ghaderi, A. A. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12407 · Cited by 22
Strobel, S. B., Safferling, K., Lahrmann, B., Hoffmann, J. H. O., Enk, A., Hadaschik, E. N., Grabe, N., & Lonsdorf, A. S. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16477 · Cited by 22
MATSUTANI, S., Shibutani, M., Maeda, K., Nagahara, H., Fukuoka, T., Iseki, Y., Kashiwagi, S., Tanaka, H., Hirakawa, K., & Ohira, M. (2018) · Anticancer Research · doi:10.21873/anticanres.13041 · Cited by 22
From the Hellstrom paradox toward cancer cure
Hellström, K. E., & Hellström, I. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.11.002 · Cited by 22
Ong, C. E. B., Patchett, A. L., Darby, J. M., Chen, J., Liu, G., Lyons, A. B., Woods, G. M., & Flies, A. S. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03601-x · Cited by 22
Ye, B., Shen, Y., Chen, H., Lin, S., Mao, W., Dong, Y., & Li, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-13272-4 · Cited by 22
Tewari, K. S., & Eskander, R. N. (2013) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s45885 · Cited by 21
Immunothérapie des cancers: Succès récents et perspectives
Tartour, É., Sandoval, F., Bonnefoy, J., & Fridman, W. H. (2011) · médecine/sciences · doi:10.1051/medsci/20112710011 · Cited by 21
Ye, S., Chen, W., Zheng, Y., Wu, Y., Xiang, L., Li, T., Ping, B., Zhang, X., & Yang, H. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-00977-3 · Cited by 20
Spiliopoulou, P., Vornicova, O., Genta, S., & Spreafico, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021294 · Cited by 20
Older Human B Cells and Antibodies
Dunn‐Walters, D. K., & O’Hare, J. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_21-1 · Cited by 20
Shang, M., Chi, Y., Zhang, J., Chang, J., Yang, H., Yin, S., Tan, Q., Man, X., & Li, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.706606 · Cited by 19
Wen, F., Lu, X., Huang, W., Chen, X., Ruan, S., Gu, S., Gu, P., Li, Y., Liu, J., Liu, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08622-1 · Cited by 19
Zahran, A. M., Hetta, H. F., Rayan, A., Eldin, A. S., Hassan, E. A., Fakhry, H., Soliman, A. S. A., & El‐Badawy, O. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02465-y · Cited by 19
Parrot, T., Oger, R., Benlalam, H., de la Blétière, D. R., Jouand, N., Coutolleau, A., Preisser, L., Khammari, A., Dréno, B., Guardiola, P., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1250991 · Cited by 19
Lam, B. M., & Verrill, C. L. (2023) · Cancers · doi:10.3390/cancers15041164 · Cited by 18
Maurer‐Granofszky, M., Müller, A. C., Parapatics, K., Pickl, W. F., Wagner, C., Rudashevskaya, E. L., Breitwieser, F. P., Colinge, J., Garg, K., Griss, J., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr401270y · Cited by 17
Tien, T. Z., Lee, J. N., Lim, J. C. T., Chen, X., Thike, A. A., Tan, P. H., & Yeong, J. P.-S. (2021) · Histopathology · doi:10.1111/his.14328 · Cited by 17
Yuan, Y., Tan, L., Wang, L., Zou, D., Liu, J., Lu, X., Fu, D., Wang, G., Wang, L., & Wang, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.814621 · Cited by 17
Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment
Talaat, I. M., Elemam, N. M., Zaher, S., & Saber-Ayad, M. M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.955599 · Cited by 17
Leiting, J. L., Hernandez, M. C., Yang, L., Bergquist, J. R., Ivanics, T., Graham, R. P., & Truty, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-42470-w · Cited by 17
Mishra, S., Patel, D. D., Bansal, D. D., & Kumar, R. (2014) · Environmental Toxicology · doi:10.1002/tox.22061 · Cited by 17
Azizi, A., Mehdipour, F., Samadi, M., Rasolmali, R., Talei, A., & Ghaderi, A. A. (2024) · BMC Immunology · doi:10.1186/s12865-024-00620-4 · Cited by 16
Medulloblastoma—Biology and Microenvironment:A Review
Byrd, T. T., Grossman, R. G., & Ahmed, N. M. (2012) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2012.698372 · Cited by 16
Pratt, H. G., Justin, E. M., & Lindsey, B. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_6 · Cited by 16
Influence of human immune cells on cancer: studies at the University of Colorado
Bruno, T. C., French, J. D., Jordan, K. R., Ramirez, O., Sippel, T. R., Borges, V. F., Haugen, B. R., McCarter, M. D., Waziri, A. E., & Slansky, J. E. (2012) · Immunologic Research · doi:10.1007/s12026-012-8346-y · Cited by 15
Bao, W., Qu, X., Wang, Y., Huang, D., Zhang, H., Dong, M., Sun, H., Yang, Z., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70599 · Cited by 15
The immune microenvironment of cancer of the uterine cervix.
Mastrogeorgiou, M., Chatzikalil, E., Theocharis, S. E., Papoudou‐Bai, A., Péoc’h, M., Mobarki, M., & Karpathiou, G. (2024) · PubMed · doi:10.14670/hh-18-727 · Cited by 15
Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity
Guy, T. V., Terry, A. M., Bolton, H. A., Hancock, D. G., Zhu, E., Brink, R. A., McGuire, H. M., Shklovskaya, E., & Groth, B. F. D. S. (2016) · Oncotarget · doi:10.18632/oncotarget.8797 · Cited by 15
High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers
Rho, J.-H., & Lampe, P. D. (2014) · Proteomes · doi:10.3390/proteomes2010001 · Cited by 15
Wu, C., Hu, Q., & Ma, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-83120-4 · Cited by 14
Jang, J.-W., Park, S., & Moon, E. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107509 · Cited by 14
Ganesh, S., Dharmalingam, P., Das, S., Venkatakrishnan, K., & Tan, B. (2023) · ACS Nano · doi:10.1021/acsnano.2c09323 · Cited by 13
Shea, A. A., Heffron, C. L., Grieco, J. P., Roberts, P. C., & Schmelz, E. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323399 · Cited by 13
Hashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 13
Ellerman, D. A. (2024) · BioDrugs · doi:10.1007/s40259-024-00691-0 · Cited by 13
Mullins, C. S., Gock, M. C., Krohn, M., & Linnebacher, M. (2019) · Cancers · doi:10.3390/cancers11060776 · Cited by 13
Fagiani, E., Bill, R., Pisarsky, L., Ivánek, R., Rüegg, C., & Christofori, G. (2015) · Angiogenesis · doi:10.1007/s10456-015-9470-9 · Cited by 13
Monette, A., Bergeron, D., Amor, A. B., Meunier, L., Caron, C., Mes‐Masson, A., Kchir, N., Hamzaoui, K., Jurišica, I., & Lapointe, R. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0544-x · Cited by 13
Mungenast, F., Meshcheryakova, A., Beer, A., Salzmann, M., Tamandl, D., Gruenberger, T., Pietschmann, P., Koperek, O., Birner, P., Kirsch, I. M., et al. (2020) · Cancers · doi:10.3390/cancers12113117 · Cited by 13
The Influence of Meditative Interventions on Immune Functioning: A Meta-Analysis
Oyler, D. L., Hulett, J. M., Pratscher, S. D., Price‐Blackshear, M. A., Murphy, E. A., & Bettencourt, B. A. (2023) · Mindfulness · doi:10.1007/s12671-023-02157-w · Cited by 12
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Rosenberg, M. I., Greenstein, E., Buchkovich, M. L., Peres, A., Santoni‐Rugiu, E., Yang, L., Mikl, M., Vaksman, Z., Gibbs, D. L., Reshef, D., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112879 · Cited by 12
Louie, D., Oo, D., Leung, G., Lin, Y., Stephens, M., Alrashed, O., Tso, M., & Liao, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.825287 · Cited by 11
Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma
Vela‐Ojeda, J., Perez-Retiguin, F., Olivas‐Bejarano, A. C., Esparza, M. A. G.-R., García-Chávez, J., Majluf‐Cruz, A., Reyes‐Maldonado, E., & Montiel‐Cervantes, L. A. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1852473 · Cited by 11
Néron, S., Roy, A., Dumont, N., & Dussault, N. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.06.013 · Cited by 11
Cherukuri, A., Ding, Q., SHARMA, A. K., Mohib, K., & Rothstein, D. M. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.10.011 · Cited by 11
Shao, M., Zhai, K., Huang, Z., Yi, F., Zheng, S.-C., Liu, Y., Qiao, X., Chen, Q., Wang, Z., & Shi, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279018 · Cited by 10
Tumor‐secreted products repress B‐cell lymphopoiesis in a murine model of breast cancer
Moreau, J. M., Mielnik, M., Berger, A., Furlonger, C. L., & Paige, C. J. (2016) · European Journal of Immunology · doi:10.1002/eji.201646552 · Cited by 10
Li, C., Wan, Y., Deng, W., Fei, F., Wang, L., Fei, F., & Zheng, Z. (2022) · Journal of Oncology · doi:10.1155/2022/5185202 · Cited by 10
Shao, S., Scholtz, L. U., Gendreizig, S., Martínez-Ruiz, L., Florido, J., Escames, G., Schürmann, M., Hain, C., Hose, L., Mentz, A., et al. (2023) · BMC Cancer · doi:10.1186/s12885-022-10481-y · Cited by 10
Kotlán, B., Horváth, S., Éles, K., Plótár, V., Naszádos, G., Czirbesz, K., Blank, M., Farkas, E., Tóth, L., Tóvári, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00650 · Cited by 10
Zhong, Z., Wang, J., Han, Q., Lin, H., Luo, H., Guo, D., Jiang, Y., & Liu, A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.969536 · Cited by 9
An immune‐related gene signature for the prognosis of human bladder cancer based on WGCNA
Cheng, J., Zhang, S., Fan, A., Li, Y., Xu, P., Huang, J., He, M., & Wang, H. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106186 · Cited by 9
Colitis and Colorectal Carcinogenesis: The Focus on Isolated Lymphoid Follicles
Műzes, G., Barta, B. B., & Sípos, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020226 · Cited by 9
CoD: inferring immune-cell quantities related to disease states
Frishberg, A., Steuerman, Y., & Gat‐Viks, I. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv498 · Cited by 9
Histomorphological Spectrum of Meningioma with Variants and Grading
Raza, A. K. M. M., Ahmed, F., Ahmed, Z., Islam, R., & Khatun, T. (2017) · Cited by 9
Chen, H., Xie, H., Liu, X., Li, L., Bai, Y., & Gao, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.071 · Cited by 9
B cell extracellular vesicles influence melanoma response to immune checkpoint therapy
Hrout, A. A., Balayev, A., Cervantes-Gracia, K., Gkelis, K., Benke-Bruderer, S., Gómez, J. M. M., Siliņa, K., Levesque, M. P., & Chahwan, R. (2025) · Science Advances · doi:10.1126/sciadv.adt4551 · Cited by 8
Mir, M. A., Aisha, S., Sofi, S., & Rasheid, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18696-7.00007-5 · Cited by 8
Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer
Liu, D., Liu, L., Che, X., & Wu, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1525345 · Cited by 8
Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Gupta, S., & Dwarakanath, B. S. R. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180601101145 · Cited by 8
Prognostic Impact of Tumor Immune Microenvironment and Its Predictive Role in Salivary Gland Cancer
Veneroni, M. V., Festa, B. M., Costantino, A., Spriano, G., Mercante, G., VIRGILIO, A. D., & Tommaso, L. D. (2023) · Head and Neck Pathology · doi:10.1007/s12105-023-01528-y · Cited by 8
Wang, Z., Ren, H., Zhu, G., Zhang, L., Cao, H., & Chen, B. (2023) · BMC Cancer · doi:10.1186/s12885-023-11411-2 · Cited by 8
VII. The role of the microenvironment in lymphoid cancers
Gascoyne, R. D., & Steidl, C. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr173 · Cited by 8
Podolsky, M. A., Bailey, J. T., Gunderson, A. J., Oakes, C. J., Breech, K., & Glick, A. B. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0304 · Cited by 8
Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression
Gaggero, G., Campora, M., Taietti, D., Cerruti, G., Bue, E. L., Truffelli, M., Ceraudo, M., & Fiaschi, P. (2022) · Autopsy and Case Reports · doi:10.4322/acr.2021.394 · Cited by 7
Immune Profiling of Meningiomas
Wang, J. Z., Nassiri, F., Bi, L., & Zadeh, G. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-29750-2_14 · Cited by 7
Tumour Lymphocytic Infiltration, Its Structure and Influence in Colorectal Cancer Progression
Трајковски, Ѓ., Ognjenovic, L., Jota, G., Hadzi-Manchev, D., Trajkovska, V., Volcevski, G., Nikolova, D., Petrushevska, G., Janevska, V., & Janevski, V. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.279 · Cited by 7
Metadata
- Authors
- Nelson, B. H.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Nelson, Brad H
- ORCID
- Nelson, Brad H
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-01
- Volume
- 185
- Issue
- 9
- Pages
- 4977-4982
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2107894271
- Semantic Scholar
- bf7939d1d9b47655a2abef372b8ceeacdc5af79b
- Cited by
- 416
- References
- 96
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 20 · 2023: 27 · 2022: 26 · 2021: 25 · 2020: 47 · 2019: 35 · 2018: 30 · 2017: 23 · 2016: 36 · 2015: 30 · 2014: 31 · 2013: 24 · 2012: 17
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD20+ B cells, tumor-infiltrating lymphocytes, tertiary lymphoid structures, tumor microenvironment, autoimmunity, organ transplantation, antigen presentation, chemokines, cytokines, tumor immunology
- MeSH terms
- Animals, B-Lymphocytes, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Autoimmunity, B-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Antigens, CD20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.